Mendaera Launched Handheld Focalist Robotic System

The platform integrates Butterfly Network ultrasound-on-chip technology for clinical guidance in pediatric and adult procedures.

Updated on Oct. 5, 2026 in Robotics

A close-up view of a handheld surgical robotic tool with an ultrasound sensor probe, resting on a sterile metallic surface in a clinical setting. — Mendaera has launched the Focalist handheld robotic system in the United States, integrating ultrasound-on-chip technology to assist clinicians during medical procedures. AI Illustration. Upload story photo >

Live Poll

Do you believe robotic-assisted surgical technology will improve healthcare quality for patients?

Mendaera has released the Focalist handheld robotic system, which is now commercially available in the United States. The device is the first product to launch through the Butterfly Embedded program and carries FDA clearance for use on both pediatric and adult patients.

Why it matters

The system represents a move toward embedding sophisticated diagnostic hardware directly into surgical robotics platforms. By integrating ultrasound-on-chip technology, the device aims to provide clinicians with real-time guidance during interventions.

The Focalist platform combines robotic positioning, real-time medical imaging, and guidance software into a single handheld unit. It leverages Butterfly Network ultrasound-on-chip semiconductors to replace traditional hardware with a simplified, miniaturized silicon architecture.

The players

Mendaera

A medical technology company developing automated, software-driven intervention platforms.

Butterfly Network

A developer of portable ultrasound technology powered by proprietary semiconductor-on-chip arrays.

The details

The Focalist system integrates handheld robotics with software that interprets imaging data to direct clinical interventions. By using ultrasound-on-chip technology—a method that uses silicon chips to replace the bulky piezoelectric crystals found in traditional ultrasound systems—the device shrinks the necessary imaging hardware. This miniaturization allows the system to remain handheld while maintaining compatibility with existing FDA-cleared ultrasound probes.

October 5, 2026: The Focalist system reached commercial availability.

The Tech Race

The launch marks the first commercial deployment of the Butterfly Embedded program, which grants third-party medical device makers access to ultrasound-on-chip hardware. This shifts the competitive landscape by allowing robotics companies to integrate high-end imaging without developing original transducer physics from scratch.

Clinicians and hospital systems in the United States can now acquire the Focalist system for use in pediatric and adult care environments. The device is designed to be compatible with a range of FDA-cleared ultrasound probes already prevalent in existing clinical workflows.

The takeaway

The Focalist system demonstrates how hardware-as-a-service models are reaching surgical robotics. Interested clinicians should track upcoming clinical data to see how the system performs in specific pediatric and adult procedural benchmarks.